• Subject: Re: Java is now dead
  • From: booth@xxxxxxxxxxxx
  • Date: Tue, 30 Jan 2001 21:04:29 -0500

I sure would hate to be a firm that has committed to Microsoft as their 
platform for development.  .net sounds like everything related to Windows 
programming for the last decade is not only suddenly "legacy"  but is also 
in danger of becoming more and more unusable with each new release of the 
Windows Vision. 

It may seem trivial or even negative, but the fact that RPG and RPGII 
still runs on a 64 bit operating system seems to me to be even more 
dramatic now.


_______________________
Booth Martin
Booth@MartinVT.com
http://www.MartinVT.com
_______________________




nina jones <ddi@datadesigninc.com>
Sent by: owner-midrange-l@midrange.com
01/30/2001 08:39 PM
Please respond to MIDRANGE-L

 
        To:     MIDRANGE-L@midrange.com
        cc: 
        Subject:        Re: Java is now dead
> 
> WEB FEATURE: MICROSOFT JUMPS THE JAVA SHIP,
> WHILE IBM STAYS THE COURSE
> http://www.as400network.com/news/nwn/story.cfm?ID=9392
> Microsoft announced plans to help programmers migrate from Java to
> the Microsoft .Net platform, making the "write once, run anywhere"
> ideal seem unlikely. Still, IBM doesn't plan to back away from the
> standard -- it's Java as usual.
> 

i heard that several months ago at an asna seminar (.net not supporting
java).  it should be interesting how this plays out over the next couple
of years........

nj

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---

This thread ...

Follow-Ups:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].